Akoya Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AKYA Nasdaq 2836 www.akoyabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akoya Biosciences, Inc.

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal - May 23rd, 2025 12:21 pm
Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates - May 12th, 2025 3:30 pm
Akoya: Q1 Earnings Snapshot - May 12th, 2025 2:36 pm
Akoya Biosciences Reports First Quarter 2025 Financial Results - May 12th, 2025 2:05 pm
Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - May 5th, 2025 8:00 am
Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar? - May 1st, 2025 2:23 am
Quanterix, Akoya Biosciences Amend Merger Deal - Apr 29th, 2025 9:50 am
Quanterix and Akoya Biosciences Announce Amended Merger Agreement - Apr 29th, 2025 5:00 am
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025 - Apr 24th, 2025 6:00 am
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas - Apr 24th, 2025 6:00 am
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore - Apr 23rd, 2025 6:00 am
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities - Apr 2nd, 2025 6:00 am
Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Mar 18th, 2025 1:01 am
Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates - Mar 17th, 2025 3:10 pm
Akoya: Q4 Earnings Snapshot - Mar 17th, 2025 2:15 pm
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results - Mar 17th, 2025 2:00 pm
Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger - Mar 11th, 2025 8:39 am
Akoya Biosciences unveils strategic product roadmap - Feb 6th, 2025 6:15 am
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels - Feb 5th, 2025 6:00 am
Quanterix Agrees to Acquire Akoya Biosciences in All-Stock Deal - Jan 10th, 2025 5:49 am